M3 Biotechnology raises $15.2M, launches clinical trial for drug that could reverse Alzheimer's – GeekWire

M3 Biotechnology raises $15.2M, launches clinical trial for drug that could reverse Alzheimer’s – GeekWire

M3 Biotechnology raises $15.2M, launches clinical trial for drug that could reverse Alzheimer’s – GeekWire M3 Biotechnology founder and CEO Leen Kawas. (M3 Biotechnology Photo) Alzheimer’s remains one of the biggest puzzles in the medical world. It’s a devastating disease that impacts millions of people across the globe, but there are no treatments that can …

M3 Biotechnology raises $15.2M, launches clinical trial for drug that could reverse Alzheimer’s – GeekWire Read More »